Monte AA

Rocky Mountain Poison and Drug Safety, Denver Health and Hospital Authority, Denver, Colorado.

8 papers · ORCID

ArticlePsilocybin

Adverse Health Outcomes of Psilocybin, LSD, MDMA, Ibogaine, and 5-MeO-DMT.

Simonsson O, Bradley M, Black JC +3

Europe PMC2026
ArticlePsychedelics

Prevalence and predictors of sexual and physical violence during psychedelic use in a US population-based study.

Chwyl C, Ladka MS, Black JC +4

Europe PMC2026
ArticlePsilocybin

Fusing Specialized Surveys of Rare Populations to Larger Surveys for Generalized Inference: Cross-Sectional Survey Study.

Rockhill KM, Bemis EA, Schow N +5

Europe PMC2026
ArticlePsilocybin

Psilocybin Trends in States That Decriminalized Use.

Black JC, Bau GE, Cook RR +2

Europe PMC2026
ArticlePsilocybin

Psychedelic Terminology Preference in the 2024 National Survey Investigating Hallucinogenic Trends (NSIHT).

Lyons FE, Rockhill KM, Fox EJ +4

Europe PMC2026
ArticlePsychedelics

Psychedelic Trips: Travel Within the United States to Use Psychedelic Drugs After Legalization.

Black JC, Rockhill KM, Fox EJ +3

Europe PMC2025
ArticleKetamine

Clinical Effects of Psychedelic Substances Reported to United States Poison Centers: 2012 to 2022.

Simon MW, Olsen HA, Hoyte CO +4

Europe PMC2024
ArticlePsychedelics

Drugs of Abuse and Novel Psychoactive Substances at Outdoor Music Festivals in Colorado.

Fox J, Smith A, Yale A +4

Europe PMC2018